Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Esflurbiprofen Topical System Efts

Research Leaders

6 sponsors active, led by SocraTec R&D GmbH

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT06871046Phase 3Completed

Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With Contusions

Showing all 1 trials

Research Network

Common Treatments

  • Esflurbiprofen Topical System Efts1

Active Sponsors

  • SocraTec R&D GmbH1
  • SocraMetrics GmbH1
  • Teikoku Seiyaku Co., Ltd.1
  • HWI pharma services GmbH1
  • CRM Biometrics GmbH1

Top Investigators

Related Conditions

  • Contusions1

Activity Timeline